, Tracking Stock Market Picks
Enter Symbol:
Intuitive Surgical, Inc. (ISRG) [hlAlert]

up 188.68 %

Intuitive Surgical, Inc. (ISRG) rated Buy

Posted on: Friday,  Oct 19, 2007  9:25 AM ET by HSBC Securities

HSBC Securities rated Buy Intuitive Surgical, Inc. (NASDAQ: ISRG) on 10/19/2007. Previously HSBC Securities rated Buy Intuitive Surgical, Inc. (NASDAQ: ISRG) on
07/20/2007., when the stock price was $178.59. Since then, Intuitive Surgical, Inc. has gained 188.69% as of 01/22/2016's recent price of $515.57.
If you would have followed the previous HSBC Securities's recommendation on ISRG, you would have gained 188.68% of your investment in 3108 days.

Intuitive Surgical, Inc. designs and manufactures the da Vinci Surgical System. The da Vinci Surgical System seamlessly translates the surgeon's natural hand movements on instrument controls at a console into corresponding micromovements of instruments positioned inside the patient through small puncture incisions, or ports. The products provide the surgeon with the range of motion and fine tissue control previously possible only with open surgery, while simultaneously allowing the surgeon to work through small ports.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2007 9:25 AM Buy
269.34 325.00
as of 8/27/2015
1 Week down  -3.26 %
1 Month up  3.81 %
3 Months up  2.63 %
1 YTD up  34.23 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/20/2007 9:25 AM Buy
178.59 198.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy